Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: Grand View Research | PRODUCT CODE: 1941464

Cover Image

PUBLISHER: Grand View Research | PRODUCT CODE: 1941464

Europe Compression Therapy Market Size, Share & Trends Analysis Report By Technology, By Distribution Channel, By End Use, By Country And Segment Forecasts, 2026 - 2033

PUBLISHED:
PAGES: 120 Pages
DELIVERY TIME: 2-10 business days
SELECT AN OPTION
Unprintable PDF & Excel (Single User License)
USD 5950
Printable PDF & Excel (5-User License)
USD 6950
Printable PDF & Excel (Enterprise License)
USD 8950

Add to Cart

Europe Compression Therapy Market Summary

The Europe compression therapy market size was estimated at USD 1.25 billion in 2025 and is projected to reach USD 1.74 billion by 2033, growing at a CAGR of 4.19% from 2026 to 2033. This growth is attributed to the increasing prevalence of venous disorders, including chronic venous insufficiency, varicose veins, deep vein thrombosis (DVT), and lymphedema, particularly among aging populations and individuals with sedentary lifestyles.

The rising awareness of the clinical benefits of compression therapy in improving blood circulation, reducing edema, and preventing post-surgical complications has increased its adoption across healthcare and home care settings. Besides, expanding reimbursement coverage, technological advancements in advanced compression materials and smart wearable systems, and increased focus on preventive healthcare and patient self-management are further propelling market growth.

The increasing prevalence of chronic venous disorders, including chronic venous insufficiency (CVI), varicose veins, deep vein thrombosis (DVT), and venous leg ulcers, is a key driver of the Europe compression therapy industry. Factors such as sedentary lifestyles, obesity, aging populations, and prolonged periods of standing or sitting at work are significantly contributing to the growing burden of these conditions. According to data published by the Society for Vascular Surgery in July 2025, chronic venous insufficiency affects up to 40% of Americans. Similarly, data from WebMD LLC published in July 2025 indicate that in the U.S., more than 11 million men and 22 million women aged 40-80 years suffer from varicose veins, while over 2 million individuals are affected by advanced CVI. Each year, more than 20,000 people are diagnosed with ulcers resulting from CVI.

The rising volume of surgical procedures, including orthopedic and minimally invasive interventions, is a key driver of the Europe compression therapy industry. Even when surgeries are conducted on an outpatient or same-day basis, compression garments such as stockings or socks are commonly recommended as part of postoperative care. Patients who experience prolonged immobility following procedures involving the hip, knee, legs, or abdomen face an elevated risk of developing deep vein thrombosis (DVT). This risk increases further in longer surgeries that require general anesthesia for extended durations. As a result, the use of compression therapy until patients regain full mobility is widely regarded as an essential element of postoperative recovery and DVT prevention, supporting sustained market growth.

The increasing incidence of sports-related injuries is a significant driver of demand for compression therapy products, as athletes and fitness enthusiasts increasingly adopt compression garments to support recovery, prevent injuries, and optimize performance. Muscle strains, sprains, fatigue, and post-exercise inflammation are common among active individuals, driving the use of compression socks, sleeves, and tights to improve blood circulation, enhance oxygen delivery, and reduce muscle soreness and swelling. Compression therapy also supports lymphatic drainage and metabolic waste removal, enabling faster healing and rehabilitation while helping prevent complications such as deep vein thrombosis, particularly among athletes exposed to frequent travel or prolonged sitting. This trend is evident across Europe, including Germany, where a study published in October 2024 by the Department of Sports Medicine and Sports Nutrition at Ruhr University Bochum reported that approximately 12.2% of athletes experienced sports injuries within 12 months requiring medical attention or temporary activity cessation. The growing burden of sports injuries, combined with rising awareness of recovery-focused interventions, is reinforcing the adoption of compression therapy as a key component of modern sports medicine and active lifestyle management.

Europe Compression Therapy Market Report Segmentation

This report forecasts revenue growth at the country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the Europe compression therapy market report on the basis of technology, distribution channel, end use, and country.

  • Technology Outlook (Revenue, USD Million, 2021 - 2033)
  • Static Compression Therapy
    • Compression Bandages
    • Compression Stockings & Hosiery
    • Compression Tape
    • Adjustable Compression Wraps (Leg/Calf)
  • Dynamic Compression Therapy
    • Compression Pumps
    • Compression Sleeves
  • Distribution Channel Outlook (Revenue, USD Million, 2021 - 2033)
  • Institutional Sales
  • Retail Sales
  • End Use Outlook (Revenue, USD Million, 2021 - 2033)
  • Hospitals
  • Specialty Clinics
  • Home healthcare
  • Physician's Office
  • Nursing Homes
  • Others
  • Country Outlook (Revenue, USD Million, 2021 - 2033)
  • UK
  • France
  • Germany
  • Spain
Product Code: GVR-4-68040-843-8

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
    • 1.1.1. Technology
    • 1.1.2. Distribution Channel
    • 1.1.3. End Use
    • 1.1.4. Estimates And Forecast Timeline
  • 1.2. Research Methodology
  • 1.3. Information Procurement
    • 1.3.1. Purchased Database
    • 1.3.2. GVR's Internal Database
    • 1.3.3. Secondary Sources
    • 1.3.4. Primary Research
    • 1.3.5. Details Of Primary Research
  • 1.4. Information or Data Analysis
    • 1.4.1. Data Analysis Models
  • 1.5. Market Formulation & Validation
  • 1.6. Model Details
    • 1.6.1. Commodity Price Analysis (Model 1)
    • 1.6.2. Approach 1: Commodity Flow Approach
  • 1.7. List of Secondary Sources
  • 1.8. List of Primary Sources
  • 1.9. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Competitive Insights

Chapter 3. Europe Compression Therapy Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Related/Ancillary Market Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
      • 3.2.1.1. Increasing prevalence of chronic vein disorders
      • 3.2.1.2. Growing number of surgical and minimally invasive procedures
      • 3.2.1.3. Rising burden of obesity and older population
      • 3.2.1.4. Surge in sports related injuries
      • 3.2.1.5. Rising Incidence of venous leg ulcers
    • 3.2.2. Market Restraint Analysis
      • 3.2.2.1. Alternative treatment options
      • 3.2.2.2. Adverse effects associated with compression therapy
    • 3.2.3. Market Opportunity Analysis
      • 3.2.3.1. Increasing number of clinical trials
      • 3.2.3.2. Inclusive and expanded sizing in compression therapy garments
      • 3.2.3.3. Integration of active ingredients and textiles in compression garments
      • 3.2.3.4. Technological Advancements
      • 3.2.3.5. Growing adoption of compression therapy for lymphedema management
      • 3.2.3.6. Increasing preference for adjustable compression wraps
    • 3.2.4. Market Challenges Analysis
      • 3.2.4.1. Product recalls
  • 3.3. Europe Compression Therapy Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's Five Forces
      • 3.3.1.1. Supplier power
      • 3.3.1.2. Buyer power
      • 3.3.1.3. Substitution threat
      • 3.3.1.4. Threat of new entrant
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Technological landscape
      • 3.3.2.3. Economic landscape

Chapter 4. Europe Compression Therapy Market: Technology Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. Europe Compression Therapy Market Technology Movement Analysis
  • 4.3. Europe Compression Therapy Market Size & Trend Analysis, by Technology 2021 to 2033 (USD Million)
  • 4.4. Static Compression Therapy
    • 4.4.1. Static Compression Therapy Market Estimates and Forecasts for 2021 to 2033 (USD Million)
    • 4.4.2. Compression Bandages
      • 4.4.2.1. Compression Bandages Market Estimates and Forecasts for 2021 to 2033 (USD Million)
      • 4.4.2.2. By Indication & Pathology
        • 4.4.2.2.1. Venous Leg Ulcers
          • 4.4.2.2.1.1. Venous Leg Ulcers Market Estimates and Forecasts for 2021 to 2033 (USD Million)
        • 4.4.2.2.2. Mixed Leg Ulcers
          • 4.4.2.2.2.1. Mixed Leg Ulcers Market Estimates and Forecasts for 2021 to 2033 (USD Million)
        • 4.4.2.2.3. Post-operative Edema
          • 4.4.2.2.3.1. Post-operative Edema Market Estimates and Forecasts for 2021 to 2033 (USD Million)
        • 4.4.2.2.4. Deep Vein Thrombosis (DVT)
          • 4.4.2.2.4.1. Deep Vein Thrombosis (DVT) Market Estimates and Forecasts for 2021 to 2033 (USD Million)
        • 4.4.2.2.5. Lymphedema
          • 4.4.2.2.5.1. Lymphedema Market Estimates and Forecasts for 2021 to 2033 (USD Million)
      • 4.4.2.3. By Compression Class
        • 4.4.2.3.1. Class 1
          • 4.4.2.3.1.1. Class 1 Market Estimates and Forecasts for 2021 to 2033 (USD Million)
        • 4.4.2.3.2. Class 2
          • 4.4.2.3.2.1. Class 2 Market Estimates and Forecasts for 2021 to 2033 (USD Million)
        • 4.4.2.3.3. Class 3
          • 4.4.2.3.3.1. Class 3 Market Estimates and Forecasts for 2021 to 2033 (USD Million)
        • 4.4.2.3.4. Class 4
          • 4.4.2.3.4.1. Class 4 Market Estimates and Forecasts for 2021 to 2033 (USD Million)
    • 4.4.3. Compression Stockings & Hosiery
      • 4.4.3.1. Compression Stockings & Hosiery Market Estimates and Forecasts for 2021 to 2033 (USD Million)
      • 4.4.3.2. Medical-grade Stockings
        • 4.4.3.2.1. Medical-grade Stockings Market Estimates and Forecasts for 2021 to 2033 (USD Million)
        • 4.4.3.2.2. By Indications / Use Cases
          • 4.4.3.2.2.1. Varicose Veins
            • 4.4.3.2.2.1.1. Varicose Veins Market Estimates and Forecasts for 2021 to 2033 (USD Million)
          • 4.4.3.2.2.2. Deep Vein Thrombosis (DVT) Prevention
            • 4.4.3.2.2.2.1. Deep Vein Thrombosis (DVT) Prevention Market Estimates and Forecasts for 2021 to 2033 (USD Million)
          • 4.4.3.2.2.3. Lymphedema
            • 4.4.3.2.2.3.1. Lymphedema Market Estimates and Forecasts for 2021 to 2033 (USD Million)
          • 4.4.3.2.2.4. Chronic Venous Insufficiency
            • 4.4.3.2.2.4.1. Chronic Venous Insufficiency Market Estimates and Forecasts for 2021 to 2033 (USD Million)
          • 4.4.3.2.2.5. Post-Surgical Recovery
            • 4.4.3.2.2.5.1. Post-Surgical Recovery Market Estimates and Forecasts for 2021 to 2033 (USD Million)
          • 4.4.3.2.2.6. Other Medical Conditions
            • 4.4.3.2.2.6.1. Other Medical Conditions Market Estimates and Forecasts for 2021 to 2033 (USD Million)
        • 4.4.3.2.3. By Compression Class
          • 4.4.3.2.3.1. Class 1
            • 4.4.3.2.3.1.1. Class 1 Market Estimates and Forecasts for 2021 to 2033 (USD Million)
          • 4.4.3.2.3.2. Class 2
            • 4.4.3.2.3.2.1. Class 2 Market Estimates and Forecasts for 2021 to 2033 (USD Million)
          • 4.4.3.2.3.3. Class 3
            • 4.4.3.2.3.3.1. Class 3 Market Estimates and Forecasts for 2021 to 2033 (USD Million)
          • 4.4.3.2.3.4. Class 4
            • 4.4.3.2.3.4.1. Class 4 Market Estimates and Forecasts for 2021 to 2033 (USD Million)
      • 4.4.3.3. Socks and Tights
        • 4.4.3.3.1. Socks and Tights Market Estimates and Forecasts for 2021 to 2033 (USD Million)
        • 4.4.3.3.2. By Indications / Use Cases
          • 4.4.3.3.2.1. Everyday Wear & Comfort
            • 4.4.3.3.2.1.1. Everyday Wear & Comfort Market Estimates and Forecasts for 2021 to 2033 (USD Million)
          • 4.4.3.3.2.2. Travel & Long-haul Use
            • 4.4.3.3.2.2.1. Travel & Long-haul Use Market Estimates and Forecasts for 2021 to 2033 (USD Million)
          • 4.4.3.3.2.3. Sports & Athletic Recovery
            • 4.4.3.3.2.3.1. Sports & Athletic Recovery Market Estimates and Forecasts for 2021 to 2033 (USD Million)
          • 4.4.3.3.2.4. Others
            • 4.4.3.3.2.4.1. Others Market Estimates and Forecasts for 2021 to 2033 (USD Million)
        • 4.4.3.3.3. By Compression Class
          • 4.4.3.3.3.1. Class 1
            • 4.4.3.3.3.1.1. Class 1 Market Estimates and Forecasts for 2021 to 2033 (USD Million)
          • 4.4.3.3.3.2. Class 2
            • 4.4.3.3.3.2.1. Class 2 Market Estimates and Forecasts for 2021 to 2033 (USD Million)
          • 4.4.3.3.3.3. Class 3
            • 4.4.3.3.3.3.1. Class 3 Market Estimates and Forecasts for 2021 to 2033 (USD Million)
          • 4.4.3.3.3.4. Class 4
            • 4.4.3.3.3.4.1. Class 4 Market Estimates and Forecasts for 2021 to 2033 (USD Million)
          • 4.4.3.3.3.5. Class 5
            • 4.4.3.3.3.5.1. Class 5 Market Estimates and Forecasts for 2021 to 2033 (USD Million)
    • 4.4.4. Custom-fit Hosiery
      • 4.4.4.1. Custom-fit Hosiery Market Estimates and Forecasts for 2021 to 2033 (USD Million)
        • 4.4.4.1.1. By Indications / Use Cases
          • 4.4.4.1.1.1. Lymphedema
            • 4.4.4.1.1.1.1. Lymphedema Market Estimates and Forecasts for 2021 to 2033 (USD Million)
          • 4.4.4.1.1.2. Chronic Venous Insufficiency
            • 4.4.4.1.1.2.1. Chronic Venous Insufficiency Market Estimates and Forecasts for 2021 to 2033 (USD Million)
          • 4.4.4.1.1.3. Post-surgical Recovery
            • 4.4.4.1.1.3.1. Post-surgical Recovery Market Estimates and Forecasts for 2021 to 2033 (USD Million)
          • 4.4.4.1.1.4. Severe Varicose Veins
            • 4.4.4.1.1.4.1. Severe Varicose Veins Market Estimates and Forecasts for 2021 to 2033 (USD Million)
          • 4.4.4.1.1.5. Other Therapeutic Uses
            • 4.4.4.1.1.5.1. Other Therapeutic Uses Market Estimates and Forecasts for 2021 to 2033 (USD Million)
        • 4.4.4.1.2. By Compression Class
          • 4.4.4.1.2.1. Class 1
            • 4.4.4.1.2.1.1. Class 1 Market Estimates and Forecasts for 2021 to 2033 (USD Million)
          • 4.4.4.1.2.2. Class 2
            • 4.4.4.1.2.2.1. Class 2 Market Estimates and Forecasts for 2021 to 2033 (USD Million)
          • 4.4.4.1.2.3. Class 3
            • 4.4.4.1.2.3.1. Class 3 Market Estimates and Forecasts for 2021 to 2033 (USD Million)
          • 4.4.4.1.2.4. Class 4
            • 4.4.4.1.2.4.1. Class 4 Market Estimates and Forecasts for 2021 to 2033 (USD Million)
    • 4.4.5. Compression Tape
      • 4.4.5.1. Compression Tape Market Estimates and Forecasts for 2021 to 2033 (USD Million)
      • 4.4.5.2. By Indication & Pathology
        • 4.4.5.2.1. Sports Injuries
          • 4.4.5.2.1.1. Sports Injuries Market Estimates and Forecasts for 2021 to 2033 (USD Million)
        • 4.4.5.2.2. Post-operative Edema
          • 4.4.5.2.2.1. Post-operative Edema Market Estimates and Forecasts for 2021 to 2033 (USD Million)
        • 4.4.5.2.3. Lymphedema
          • 4.4.5.2.3.1. Lymphedema Market Estimates and Forecasts for 2021 to 2033 (USD Million)
      • 4.4.5.3. By Compression Class
        • 4.4.5.3.1. Class 1
          • 4.4.5.3.1.1. Class 1 Market Estimates and Forecasts for 2021 to 2033 (USD Million)
        • 4.4.5.3.2. Class 2
          • 4.4.5.3.2.1. Class 2 Market Estimates and Forecasts for 2021 to 2033 (USD Million)
    • 4.4.6. Adjustable Compression Wraps (Leg/Calf)
      • 4.4.6.1. Adjustable Compression Wraps (Leg/Calf) Market Estimates and Forecasts for 2021 to 2033 (USD Million)
      • 4.4.6.2. By Indication & Pathology
        • 4.4.6.2.1. Venous Leg Ulcers (VLU)
          • 4.4.6.2.1.1. Venous Leg Ulcers (VLU) Market Estimates and Forecasts for 2021 to 2033 (USD Million)
        • 4.4.6.2.2. Lymphedema
          • 4.4.6.2.2.1. Lymphedema Market Estimates and Forecasts for 2021 to 2033 (USD Million)
        • 4.4.6.2.3. Deep Vein Thrombosis (DVT)/Post-thrombotic Syndrome
          • 4.4.6.2.3.1. Deep Vein Thrombosis (DVT)/Post-thrombotic Syndrome Market Estimates and Forecasts for 2021 to 2033 (USD Million)
        • 4.4.6.2.4. Chronic Venous Insufficiency
          • 4.4.6.2.4.1. Chronic Venous Insufficiency Market Estimates and Forecasts for 2021 to 2033 (USD Million)
        • 4.4.6.2.5. Post-operative Edema
          • 4.4.6.2.5.1. Post-operative Edema Market Estimates and Forecasts for 2021 to 2033 (USD Million)
        • 4.4.6.2.6. Pregnancy-related Edema
          • 4.4.6.2.6.1. Pregnancy-related Edema Market Estimates and Forecasts for 2021 to 2033 (USD Million)
      • 4.4.6.3. By Chronic Venous Insufficiency
        • 4.4.6.3.1. Class 1
          • 4.4.6.3.1.1. Class 1 Market Estimates and Forecasts for 2021 to 2033 (USD Million)
        • 4.4.6.3.2. Class 2
          • 4.4.6.3.2.1. Class 2 Market Estimates and Forecasts for 2021 to 2033 (USD Million)
        • 4.4.6.3.3. Class 3
          • 4.4.6.3.3.1. Class 3 Market Estimates and Forecasts for 2021 to 2033 (USD Million)
        • 4.4.6.3.4. Class 4
          • 4.4.6.3.4.1. Class 4 Market Estimates and Forecasts for 2021 to 2033 (USD Million)
        • 4.4.6.3.5. Class 5
          • 4.4.6.3.5.1. Class 5 Market Estimates and Forecasts for 2021 to 2033 (USD Million)
        • 4.4.6.3.6. Class 6
          • 4.4.6.3.6.1. Class 6 Market Estimates and Forecasts for 2021 to 2033 (USD Million)
  • 4.5. Dynamic Compression Therapy
    • 4.5.1. Dynamic Compression Therapy Market Estimates and Forecasts for 2021 to 2033 (USD Million)
    • 4.5.2. Compression Pumps
      • 4.5.2.1. Compression Pumps Market Estimates and Forecasts for 2021 to 2033 (USD Million)
    • 4.5.3. Compression Sleeves
      • 4.5.3.1. Compression Sleeves Market Estimates and Forecasts for 2021 to 2033 (USD Million)
      • 4.5.3.2. By Indication & Pathology
        • 4.5.3.2.1. Lymphedema
          • 4.5.3.2.1.1. Lymphedema Market Estimates and Forecasts for 2021 to 2033 (USD Million)
        • 4.5.3.2.2. Sports Recovery
          • 4.5.3.2.2.1. Sports Recovery Market Estimates and Forecasts for 2021 to 2033 (USD Million)
        • 4.5.3.2.3. Post-operative Edema
          • 4.5.3.2.3.1. Post-operative Edema Market Estimates and Forecasts for 2021 to 2033 (USD Million)
        • 4.5.3.2.4. CVI Prevention
          • 4.5.3.2.4.1. CVI Prevention Market Estimates and Forecasts for 2021 to 2033 (USD Million)
      • 4.5.3.3. By Compression Class
        • 4.5.3.3.1. Class 1
          • 4.5.3.3.1.1. Class 1 Market Estimates and Forecasts for 2021 to 2033 (USD Million)
        • 4.5.3.3.2. Class 2
          • 4.5.3.3.2.1. Class 2 Market Estimates and Forecasts for 2021 to 2033 (USD Million)
        • 4.5.3.3.3. Class 3 and 4
          • 4.5.3.3.3.1. Class 3 and 4 Market Estimates and Forecasts for 2021 to 2033 (USD Million)

Chapter 5. Europe Compression Therapy Market: Distribution Channel Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. Europe Compression Therapy Market Distribution Channel Movement Analysis
  • 5.3. Europe Compression Therapy Market Size & Trend Analysis, by Distribution Channel, 2021 to 2033 (USD Million)
  • 5.4. Institutional Sales
    • 5.4.1. Institutional Sales Market Estimates and Forecasts for 2021 to 2033 (USD Million)
  • 5.5. Retail Sales
    • 5.5.1. Retail Sales Market Estimates and Forecasts for 2021 to 2033 (USD Million)

Chapter 6. Europe Compression Therapy Market: End Use Estimates & Trend Analysis

  • 6.1. Segment Dashboard
  • 6.2. Europe Compression Therapy Market End Use Movement Analysis
  • 6.3. Europe Compression Therapy Market Size & Trend Analysis, by End Use 2021 to 2033 (USD Million)
  • 6.4. Hospitals
    • 6.4.1. Hospitals Market Estimates and Forecasts for 2021 to 2033 (USD Million)
  • 6.5. Specialty Clinics
    • 6.5.1. Specialty Clinics Market Estimates and Forecasts for 2021 to 2033 (USD Million)
  • 6.6. Home Healthcare
    • 6.6.1. Home Healthcare Market Estimates and Forecasts for 2021 to 2033 (USD Million)
  • 6.7. Physician's Office
    • 6.7.1. Physician's Office Market Estimates and Forecasts for 2021 to 2033 (USD Million)
  • 6.8. Nursing Homes
    • 6.8.1. Nursing Homes Market Estimates and Forecasts for 2021 to 2033 (USD Million)
  • 6.9. Others
    • 6.9.1. Others Market Estimates and Forecasts for 2021 to 2033 (USD Million)

Chapter 7. Europe Compression Therapy Market: Regional Estimates & Trend Analysis by Technology, Distribution Channel, End Use

  • 7.1. Regional Outlook
  • 7.2. Europe Compression Therapy Market: Regional Movement Analysis & Market Share, 2025 & 2033
  • 7.3. Europe
    • 7.3.1. UK
      • 7.3.1.1. Key Country Dynamics
      • 7.3.1.2. Competitive Scenario
      • 7.3.1.3. Regulatory Scenario
      • 7.3.1.4. Reimbursement Scenario
      • 7.3.1.5. UK Compression Therapy Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.3.2. France
      • 7.3.2.1. Key Country Dynamics
      • 7.3.2.2. Competitive Scenario
      • 7.3.2.3. Regulatory Scenario
      • 7.3.2.4. Reimbursement Scenario
      • 7.3.2.5. France Compression Therapy Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.3.3. Germany
      • 7.3.3.1. Key Country Dynamics
      • 7.3.3.2. Competitive Scenario
      • 7.3.3.3. Regulatory Scenario
      • 7.3.3.4. Reimbursement Scenario
      • 7.3.3.5. Germany Compression Therapy Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 7.3.4. Spain
      • 7.3.4.1. Key Country Dynamics
      • 7.3.4.2. Competitive Scenario
      • 7.3.4.3. Regulatory Scenario
      • 7.3.4.4. Reimbursement Scenario
      • 7.3.4.5. Spain Compression Therapy Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 8.2. Company/Competition Categorization
    • 8.2.1. Innovators
  • 8.3. Vendor Landscape
    • 8.3.1. Key company market share analysis, 2025
    • 8.3.2. Essity Aktiebolag
      • 8.3.2.1. Company overview
      • 8.3.2.2. Financial performance
      • 8.3.2.3. Usage benchmarking
      • 8.3.2.4. Strategic initiatives
    • 8.3.3. Cardinal Health
      • 8.3.3.1. Company overview
      • 8.3.3.2. Financial performance
      • 8.3.3.3. Usage benchmarking
      • 8.3.3.4. Strategic initiatives
    • 8.3.4. Hartmann AG
      • 8.3.4.1. Company overview
      • 8.3.4.2. Financial performance
      • 8.3.4.3. Usage benchmarking
      • 8.3.4.4. Strategic initiatives
    • 8.3.5. ArjoHuntleigh
      • 8.3.5.1. Company overview
      • 8.3.5.2. Financial performance
      • 8.3.5.3. Usage benchmarking
      • 8.3.5.4. Strategic initiatives
    • 8.3.6. Solventum
      • 8.3.6.1. Company overview
      • 8.3.6.2. Financial performance
      • 8.3.6.3. Usage benchmarking
      • 8.3.6.4. Strategic initiatives
    • 8.3.7. Tactile Medical
      • 8.3.7.1. Company overview
      • 8.3.7.2. Financial performance
      • 8.3.7.3. Usage benchmarking
      • 8.3.7.4. Strategic initiatives
    • 8.3.8. Julius Zorn GmbH
      • 8.3.8.1. Company overview
      • 8.3.8.2. Financial performance
      • 8.3.8.3. Usage benchmarking
      • 8.3.8.4. Strategic initiatives
    • 8.3.9. Medi GmbH & Co.
      • 8.3.9.1. Company overview
      • 8.3.9.2. Financial performance
      • 8.3.9.3. Usage benchmarking
      • 8.3.9.4. Strategic initiatives
    • 8.3.10. SIGVARIS
      • 8.3.10.1. Company overview
      • 8.3.10.2. Financial performance
      • 8.3.10.3. Usage benchmarking
      • 8.3.10.4. Strategic initiatives
    • 8.3.11. URGO MEDICAL
      • 8.3.11.1. Company overview
      • 8.3.11.2. Financial performance
      • 8.3.11.3. Usage benchmarking
      • 8.3.11.4. Strategic initiatives
    • 8.3.12. Medline Industries, LP.
      • 8.3.12.1. Company overview
      • 8.3.12.2. Financial performance
      • 8.3.12.3. Usage benchmarking
      • 8.3.12.4. Strategic initiatives
    • 8.3.13. Smith+Nephew
      • 8.3.13.1. Company overview
      • 8.3.13.2. Financial performance
      • 8.3.13.3. Usage benchmarking
      • 8.3.13.4. Strategic initiatives
    • 8.3.14. Molnlycke Health Care AB
      • 8.3.14.1. Company overview
      • 8.3.14.2. Financial performance
      • 8.3.14.3. Usage benchmarking
      • 8.3.14.4. Strategic initiatives
    • 8.3.15. L&R Group
      • 8.3.15.1. Company overview
      • 8.3.15.2. Financial performance
      • 8.3.15.3. Usage benchmarking
      • 8.3.15.4. Strategic initiatives
    • 8.3.16. Ofa Bamberg GmbH
      • 8.3.16.1. Company overview
      • 8.3.16.2. Financial performance
      • 8.3.16.3. Usage benchmarking
      • 8.3.16.4. Strategic initiatives
    • 8.3.17. Zimmer Biomet
      • 8.3.17.1. Company overview
      • 8.3.17.2. Financial performance
      • 8.3.17.3. Usage benchmarking
      • 8.3.17.4. Strategic initiatives
Product Code: GVR-4-68040-843-8

List of Tables

  • Table 1 List of secondary sources
  • Table 2 List of abbreviations
  • Table 3 Europe compression therapy market, by country, 2021 - 2033 (USD Million)
  • Table 4 Europe compression therapy market, by technology, 2021 - 2033 (USD Million)
  • Table 5 Europe compression therapy market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 6 Europe compression therapy market, by end use, 2021 - 2033 (USD Million)
  • Table 7 UK compression therapy market, by technology, 2021 - 2033 (USD Million)
  • Table 8 UK compression therapy market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 9 UK compression therapy market, by end use, 2021 - 2033 (USD Million)
  • Table 10 France compression therapy market, by technology, 2021 - 2033 (USD Million)
  • Table 11 France compression therapy market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 12 France compression therapy market, by end use, 2021 - 2033 (USD Million)
  • Table 13 Germany compression therapy market, by technology, 2021 - 2033 (USD Million)
  • Table 14 Germany compression therapy market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 15 Germany compression therapy market, by end use, 2021 - 2033 (USD Million)
  • Table 16 Spain compression therapy market, by technology, 2021 - 2033 (USD Million)
  • Table 17 Spain compression therapy market, by distribution channel, 2021 - 2033 (USD Million)
  • Table 18 Spain compression therapy market, by end use, 2021 - 2033 (USD Million)

List of Figures

  • Fig. 1 Information Procurement
  • Fig. 2 Primary Research Pattern
  • Fig. 3 Market Research Approaches
  • Fig. 4 Value Chain-Based Sizing & Forecasting
  • Fig. 5 Market Formulation & Validation
  • Fig. 6 Europe Compression Therapy Market, Market Segmentation
  • Fig. 7 Market Driver Analysis (Current & Future Impact)
  • Fig. 8 Market Restraint Analysis (Current & Future Impact)
  • Fig. 9 Market Opportunity Analysis (Current & Future Impact)
  • Fig. 10 Market Challenge Analysis (Current & Future Impact)
  • Fig. 11 SWOT Analysis, By Factor (Political & Legal, Economic and Technological)
  • Fig. 12 Porter's Five Forces Analysis
  • Fig. 13 Europe Compression Therapy Market: Technology movement analysis
  • Fig. 14 Compression Bandages Market Estimates and Forecast, 2021 - 2033 (USD Million)
  • Fig. 15 Venous Leg Ulcers Market Estimates and Forecast, 2021 - 2033 (USD Million)
  • Fig. 16 Mixed Leg Ulcers Market Estimates and Forecast, 2021 - 2033 (USD Million)
  • Fig. 17 Post-operative Edema Market Estimates and Forecast, 2021 - 2033 (USD Million)
  • Fig. 18 Deep Vein Thrombosis (DVT) Market Estimates and Forecast, 2021 - 2033 (USD Million)
  • Fig. 19 Lymphedema Market Estimates and Forecast, 2021 - 2033 (USD Million)
  • Fig. 20 Class 1 Market Estimates and Forecast, 2021 - 2033 (USD Million)
  • Fig. 21 Class 2 Market Estimates and Forecast, 2021 - 2033 (USD Million)
  • Fig. 22 Class 3 Market Estimates and Forecast, 2021 - 2033 (USD Million)
  • Fig. 23 Class 4 Market Estimates and Forecast, 2021 - 2033 (USD Million)
  • Fig. 24 Compression Stockings & Hosiery Market Estimates and Forecast, 2021 - 2033 (USD Million)
  • Fig. 25 Medical-grade Stockings Market Estimates and Forecast, 2021 - 2033 (USD Million)
  • Fig. 26 Varicose Veins Market Estimates and Forecast, 2021 - 2033 (USD Million)
  • Fig. 27 Deep Vein Thrombosis (DVT) Prevention Market Estimates and Forecast, 2021 - 2033 (USD Million)
  • Fig. 28 Lymphedema Market Estimates and Forecast, 2021 - 2033 (USD Million)
  • Fig. 29 Chronic Venous Insufficiency Market Estimates and Forecast, 2021 - 2033 (USD Million)
  • Fig. 30 Post-Surgical Recovery Market Estimates and Forecast, 2021 - 2033 (USD Million)
  • Fig. 31 Other Medical Conditions Market Estimates and Forecast, 2021 - 2033 (USD Million)
  • Fig. 32 Class 1 Market Estimates and Forecast, 2021 - 2033 (USD Million)
  • Fig. 33 Class 2 Market Estimates and Forecast, 2021 - 2033 (USD Million)
  • Fig. 34 Class 3 Market Estimates and Forecast, 2021 - 2033 (USD Million)
  • Fig. 35 Class 4 Market Estimates and Forecast, 2021 - 2033 (USD Million)
  • Fig. 36 Socks and Tights Market Estimates and Forecast, 2021 - 2033 (USD Million)
  • Fig. 37 Everyday Wear & Comfort Market Estimates and Forecast, 2021 - 2033 (USD Million)
  • Fig. 38 Travel & Long-haul Use Market Estimates and Forecast, 2021 - 2033 (USD Million)
  • Fig. 39 Sports & Athletic Recovery Market Estimates and Forecast, 2021 - 2033 (USD Million)
  • Fig. 40 Others Market Estimates and Forecast, 2021 - 2033 (USD Million)
  • Fig. 41 Class 1 Market Estimates and Forecast, 2021 - 2033 (USD Million)
  • Fig. 42 Class 2 Market Estimates and Forecast, 2021 - 2033 (USD Million)
  • Fig. 43 Class 3 Market Estimates and Forecast, 2021 - 2033 (USD Million)
  • Fig. 44 Class 4 Market Estimates and Forecast, 2021 - 2033 (USD Million)
  • Fig. 45 Class 5 Market Estimates and Forecast, 2021 - 2033 (USD Million)
  • Fig. 46 Custom-fit Hosiery Market Estimates and Forecast, 2021 - 2033 (USD Million)
  • Fig. 47 Lymphedema Market Estimates and Forecast, 2021 - 2033 (USD Million)
  • Fig. 48 Chronic Venous Insufficiency Market Estimates and Forecast, 2021 - 2033 (USD Million)
  • Fig. 49 Post-surgical Recovery Market Estimates and Forecast, 2021 - 2033 (USD Million)
  • Fig. 50 Severe Varicose Veins Market Estimates and Forecast, 2021 - 2033 (USD Million)
  • Fig. 51 Other Therapeutic Uses Market Estimates and Forecast, 2021 - 2033 (USD Million)
  • Fig. 52 Class 1 Market Estimates and Forecast, 2021 - 2033 (USD Million)
  • Fig. 53 Class 2 Market Estimates and Forecast, 2021 - 2033 (USD Million)
  • Fig. 54 Class 3 Market Estimates and Forecast, 2021 - 2033 (USD Million)
  • Fig. 55 Class 4 Market Estimates and Forecast, 2021 - 2033 (USD Million)
  • Fig. 56 Compression Tape Market Estimates and Forecast, 2021 - 2033 (USD Million)
  • Fig. 57 Sports Injuries Market Estimates and Forecast, 2021 - 2033 (USD Million)
  • Fig. 58 Post-operative Edema Market Estimates and Forecast, 2021 - 2033 (USD Million)
  • Fig. 59 Lymphedema Market Estimates and Forecast, 2021 - 2033 (USD Million)
  • Fig. 60 Class 1 Market Estimates and Forecast, 2021 - 2033 (USD Million)
  • Fig. 61 Class 2 Market Estimates and Forecast, 2021 - 2033 (USD Million)
  • Fig. 62 Adjustable Compression Wraps (Leg/Calf) Market Estimates and Forecast, 2021 - 2033 (USD Million)
  • Fig. 63 Venous Leg Ulcers (VLU) Market Estimates and Forecast, 2021 - 2033 (USD Million)
  • Fig. 64 Lymphedema Market Estimates and Forecast, 2021 - 2033 (USD Million)
  • Fig. 65 Deep Vein Thrombosis (DVT)/Post-thrombotic Syndrome Market Estimates and Forecast, 2021 - 2033 (USD Million)
  • Fig. 66 Chronic Venous Insufficiency Market Estimates and Forecast, 2021 - 2033 (USD Million)
  • Fig. 67 Post-operative Edema Market Estimates and Forecast, 2021 - 2033 (USD Million)
  • Fig. 68 Pregnancy-related Edema Market Estimates and Forecast, 2021 - 2033 (USD Million)
  • Fig. 69 Class 1 Market Estimates and Forecast, 2021 - 2033 (USD Million)
  • Fig. 70 Class 2 Market Estimates and Forecast, 2021 - 2033 (USD Million)
  • Fig. 71 Class 3 Market Estimates and Forecast, 2021 - 2033 (USD Million)
  • Fig. 72 Class 4 Market Estimates and Forecast, 2021 - 2033 (USD Million)
  • Fig. 73 Class 5 Market Estimates and Forecast, 2021 - 2033 (USD Million)
  • Fig. 74 Class 6 Market Estimates and Forecast, 2021 - 2033 (USD Million)
  • Fig. 75 Dynamic Compression Therapy Market Estimates and Forecast, 2021 - 2033 (USD Million)
  • Fig. 76 Compression Pumps Market Estimates and Forecast, 2021 - 2033 (USD Million)
  • Fig. 77 Lymphedema Market Estimates and Forecast, 2021 - 2033 (USD Million)
  • Fig. 78 Sports Recovery Market Estimates and Forecast, 2021 - 2033 (USD Million)
  • Fig. 79 Post-operative Edema Market Estimates and Forecast, 2021 - 2033 (USD Million)
  • Fig. 80 CVI Prevention Market Estimates and Forecast, 2021 - 2033 (USD Million)
  • Fig. 81 Class 1 Market Estimates and Forecast, 2021 - 2033 (USD Million)
  • Fig. 82 Class 2 Market Estimates and Forecast, 2021 - 2033 (USD Million)
  • Fig. 83 Class 3 and 4 Market Estimates and Forecast, 2021 - 2033 (USD Million)
  • Fig. 84 Dental Implant Market: Procedure Movement Analysis
  • Fig. 85 Colorectal Market Estimates and Forecast, 2021 - 2033 (USD Million)
  • Fig. 86 Thoracic Market Estimates and Forecast, 2021 - 2033 (USD Million)
  • Fig. 87 Orthopedic Market Estimates and Forecast, 2021 - 2033 (USD Million)
  • Fig. 88 Ophthalmology Market Estimates and Forecast, 2021 - 2033 (USD Million)
  • Fig. 89 Neurosurgery Market Estimates and Forecast, 2021 - 2033 (USD Million)
  • Fig. 90 Cardiac surgery Market Estimates and Forecast, 2021 - 2033 (USD Million)
  • Fig. 91 Gynecology Market Estimates and Forecast, 2021 - 2033 (USD Million)
  • Fig. 92 General surgery Market Estimates and Forecast, 2021 - 2033 (USD Million)
  • Fig. 93 Urology Market Estimates and Forecast, 2021 - 2033 (USD Million)
  • Fig. 94 Others Market Estimates and Forecast, 2021 - 2033 (USD Million)
  • Fig. 95 Europe Compression Therapy Market: Distribution Channel Movement Analysis
  • Fig. 96 Institutional Sales Market Estimates and Forecast, 2021 - 2033 (USD Million)
  • Fig. 97 Retail Sales Market Estimates and Forecast, 2021 - 2033 (USD Million)
  • Fig. 98 Europe Compression Therapy Market: End Use Movement Analysis
  • Fig. 99 Hospitals Market Estimates and Forecast, 2021 - 2033 (USD Million)
  • Fig. 100 Specialty Clinics Market Estimates and Forecast, 2021 - 2033 (USD Million)
  • Fig. 101 Home Healthcare Market Estimates and Forecast, 2021 - 2033 (USD Million)
  • Fig. 102 Physician's Office Market Estimates and Forecast, 2021 - 2033 (USD Million)
  • Fig. 103 Nursing Homes Market Estimates and Forecast, 2021 - 2033 (USD Million)
  • Fig. 104 Others Market Estimates and Forecast, 2021 - 2033 (USD Million)
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!